speb/financial-data huggingface dataset:
Financial ratios for CYRE3.SA — annual report dated 2023-12-31
Total revenue: 1289216288.6597939
Gross profit: 421360618.55670106
Operating income: 171064329.89690724
Net income: 227979381.443299
Capital expenditures: 25706597.93814433
Operating cash flow: -126945567.0103093
Depreciation & amortization: 13832577.31958763
Net tangible assets: 1546930103.0927837
Owner earnings: 216105360.8247423
Return on net tangible assets (%): 13.969949928098362
Capex to operating income (%): 15.027444911301227
Buffett classification: The Great
Stock price: 4.279503105590062
P/E ratio: 6.8768609414162185
Shares outstanding: 366346855
Book value: 1752541443.298969
P/B ratio: 0.8945765646171948
Market cap (USD): 1567782503.6956522
Debt to equity: 0.6067815976468225
Current ratio: 2.8278292164391683
Quick ratio: 1.7564130102501632
Effective tax rate (%): 12.399749328757236
Interest coverage ratio: 1.822335560563529
COGS to revenue (%): 67.31653002967198
SG&A to revenue (%): 13.94504996962112
Free cash flow (dilution-adjusted): -155904123.71134022
Buyback yield (%): 0
Retained earnings: 0
Inventory turnover: 1.1372617150169289
Receivables turnover: 2.1879950170240017
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.961579142815427
FCF margin (%): -12.092937785746603
Revenue growth (%): 25.770343340924917
Rule of 40 score: 13.677405555178314
Financial ratios for CYRE3.SA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.3388581952117864
Shares outstanding: 366346855
Market cap (USD): 1223180199.106814
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYRE3.SA — annual report dated 2024-12-31
Total revenue: 1288946278.3171523
Gross profit: 417453883.4951457
Operating income: 209923948.22006473
Net income: 310849838.1877023
Capital expenditures: 22962944.98381877
Operating cash flow: 10266828.478964401
Depreciation & amortization: 8222491.909385114
Net tangible assets: 1415388025.8899677
Owner earnings: 296109385.1132686
Return on net tangible assets (%): 20.92072136381689
Capex to operating income (%): 10.938697170342165
Buffett classification: The Great
Stock price: 2.418416801292407
P/E ratio: 2.8501844955043762
Shares outstanding: 366346855
Book value: 1609914886.731392
P/B ratio: 0.5503268505277543
Market cap (USD): 885979389.2326334
Debt to equity: 0.6005041171848317
Current ratio: 3.272327397367575
Quick ratio: 1.985748820324718
Effective tax rate (%): 8.80282860238065
Interest coverage ratio: 2.83097260743285
COGS to revenue (%): 67.61277870787808
SG&A to revenue (%): 9.844761682857776
Free cash flow (dilution-adjusted): -18989482.20064725
Buyback yield (%): 0
Retained earnings: 0
Inventory turnover: 1.1306946232717028
Receivables turnover: 2.1525093415971024
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.396968253924811
FCF margin (%): -1.473256296254636
Revenue growth (%): -0.020943758236430722
Rule of 40 score: -1.4942000544910667
Financial ratios for CYRE3.SA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.418416801292407
Shares outstanding: 366346855
Market cap (USD): 885979389.2326334
Buyback yield (%): 0
Retained earnings: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYRE3.SA — quarterly report dated 2025-03-31
Total revenue: 339018055.5555556
Gross profit: 110128298.61111112
Operating income: 47251562.5
Net income: 68370312.5
Capital expenditures: 5990277.777777778
Operating cash flow: -21160069.444444444
Depreciation & amortization: 3710590.277777778
Net tangible assets: 1599103993.0555556
Owner earnings: 66090625
Return on net tangible assets (%): 4.132978548425393
Capex to operating income (%): 12.677417339961568
Buffett classification: The Great
Stock price: 3.664930555555556
P/E ratio: 4.909425354832116
Shares outstanding: 366346855
Book value: 1808591319.4444444
P/B ratio: 0.7423654909687424
Market cap (USD): 1342635782.8211806
Debt to equity: 0.5776305338927262
Current ratio: 3.363261605964145
Quick ratio: 1.9909259215504471
Effective tax rate (%): 10.08076024687017
Interest coverage ratio: 1.9488249867533547
COGS to revenue (%): 67.5155063848615
SG&A to revenue (%): 11.766826578394301
Free cash flow (dilution-adjusted): -27351215.27777778
Buyback yield (%): 0
Retained earnings: 56880555.55555556
Inventory turnover: 0.260908688638008
Receivables turnover: 0.5178881819556092
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4982677677528347
FCF margin (%): -8.06777539708226
Rule of 40 score: -8.06777539708226
Financial ratios for CYRE3.SA — quarterly report dated 2025-06-30
Total revenue: 384512773.7226277
Gross profit: 125882481.75182481
Operating income: 56720437.95620438
Net income: 87409306.56934306
Capital expenditures: 8819160.583941605
Operating cash flow: -104579744.52554743
Depreciation & amortization: 2510036.4963503648
Net tangible assets: 1762256021.89781
Owner earnings: 81100182.48175181
Return on net tangible assets (%): 4.602065844803489
Capex to operating income (%): 15.54847053675988
Buffett classification: The Great
Stock price: 4.397810218978102
P/E ratio: 10.342328169979158
Shares outstanding: 366346855
Book value: 1984464963.5036492
P/B ratio: 0.8118681721470092
Market cap (USD): 1611123942.609489
Debt to equity: 0.6335420347171111
Current ratio: 3.3611061633332477
Quick ratio: 1.9806888441739636
Effective tax rate (%): 9.406017369727047
Interest coverage ratio: 1.9817021466506004
COGS to revenue (%): 67.26182058060016
SG&A to revenue (%): 12.06726685111977
Free cash flow (dilution-adjusted): -113399087.59124087
Buyback yield (%): 0
Retained earnings: 130554562.04379562
Inventory turnover: 0.26088206600769415
Receivables turnover: 0.5335759894982923
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5956887019913202
FCF margin (%): -29.4916307963913
Revenue growth (%): 13.419556103735838
Rule of 40 score: -16.072074692655463
Financial ratios for CYRE3.SA — quarterly report dated 2025-09-30
Total revenue: 400083834.58646613
Gross profit: 132032706.76691729
Operating income: 57361278.19548872
Net income: 128376503.75939849
Capital expenditures: 10382706.766917292
Operating cash flow: 62885150.375939846
Depreciation & amortization: 2312218.0451127817
Net tangible assets: 1940155451.1278195
Owner earnings: 120306015.03759399
Return on net tangible assets (%): 6.200844111107678
Capex to operating income (%): 18.100549871871333
Buffett classification: The Great
Stock price: 5.321428571428571
P/E ratio: 6.860625074142569
Shares outstanding: 366346855
Book value: 2159576879.699248
P/B ratio: 0.9027178608809213
Market cap (USD): 1949488621.25
Debt to equity: 0.652488056131157
Current ratio: 3.5093629292535984
Quick ratio: 2.133381287000037
Effective tax rate (%): 7.558171799518952
Interest coverage ratio: 1.9041919904154552
COGS to revenue (%): 66.99873992574864
SG&A to revenue (%): 12.572552932984909
Free cash flow (dilution-adjusted): 52502443.60902255
Buyback yield (%): 0
Retained earnings: 248976315.78947368
Inventory turnover: 0.25049368633062385
Receivables turnover: 0.5399303666216396
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4662024907693896
FCF margin (%): 13.122860528291532
Revenue growth (%): 4.049556198897773
Rule of 40 score: 17.172416727189304
Financial ratios for CYRE3.SA — annual report dated 2025-12-31
Total revenue: 1719615693.430657
Gross profit: 560213321.1678832
Operating income: 264526277.37226275
Net income: 437195072.9927007
Capital expenditures: 113111313.86861312
Operating cash flow: -65399087.59124087
Depreciation & amortization: 14477737.226277372
Net tangible assets: 1846483941.6058393
Owner earnings: 338561496.3503649
Return on net tangible assets (%): 18.335469305837925
Capex to operating income (%): 42.75995375288699
Buffett classification: The Good
Stock price: 5.317773788150808
P/E ratio: 4.456019345220321
Shares outstanding: 366346855
Book value: 2092478832.1167884
P/B ratio: 0.9310248079879987
Market cap (USD): 1948149702.8904846
Debt to equity: 0.7601153034713132
Current ratio: 3.843173027370332
Quick ratio: 2.3506830565079424
Effective tax rate (%): 5.8191488525311925
Interest coverage ratio: 2.3203985132586973
COGS to revenue (%): 67.42217907710238
SG&A to revenue (%): 11.270999907253083
Free cash flow (dilution-adjusted): -180811496.35036495
Buyback yield (%): 0
Inventory turnover: 1.1002192117761693
Receivables turnover: 2.058493269781077
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.517830393985484
FCF margin (%): -10.514645629317533
Revenue growth (%): 33.412518609835814
Rule of 40 score: 22.89787298051828
Financial ratios for CYRE3.SA — quarterly report dated 2025-12-31
Total revenue: 590360218.9781021
Gross profit: 190397810.21897808
Operating income: 102453649.63503648
Net income: 153293795.62043795
Capital expenditures: 87916240.8759124
Operating cash flow: 372810.21897810214
Depreciation & amortization: 5822810.218978101
Net tangible assets: 1846483941.6058393
Owner earnings: 71200364.96350366
Return on net tangible assets (%): 3.8559969766962903
Capex to operating income (%): 85.81074582417544
Buffett classification: The Gruesome
Stock price: 5.317773788150808
P/E ratio: 4.453423399407513
Shares outstanding: 366346855
Book value: 2092478832.1167884
P/B ratio: 0.9310248079879987
Market cap (USD): 1948149702.8904846
Debt to equity: 0.7601153034713132
Current ratio: 3.843173027370332
Quick ratio: 2.3506830565079424
Effective tax rate (%): -0.2018230875115404
Interest coverage ratio: 3.3428159756126603
COGS to revenue (%): 67.74887533097139
SG&A to revenue (%): 9.598587278458593
Free cash flow (dilution-adjusted): -89633211.67883211
Buyback yield (%): 0
Inventory turnover: 0.3795458217376555
Receivables turnover: 0.7067000738336252
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.524420326779985
FCF margin (%): -15.182800059594943
Revenue growth (%): 47.55912834826457
Rule of 40 score: 32.376328288669626
Financial ratios for DARE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24
Shares outstanding: 14979502
Market cap (USD): 359508048
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DARE — annual report dated 2022-12-31
Total revenue: 1919039
Operating income: -31385488
Net income: -30947738
Capital expenditures: 63069
Operating cash flow: -18088429
Depreciation & amortization: 24202
Net tangible assets: 11112110
Owner earnings: -30986605
Return on net tangible assets (%): -278.8543759915984
Buffett classification: The Gruesome
Stock price: 9.96
Shares outstanding: 14979502
Book value: 11112110
P/B ratio: 13.426418557771658
Market cap (USD): 149195839.92000002
Debt to equity: 0.043982375984399004
Current ratio: 1.3609553614261758
Quick ratio: 1.3609553614261758
COGS to revenue (%): 0
R&D to revenue (%): 1565.4823586180373
SG&A to revenue (%): 585.8802765342446
Free cash flow (dilution-adjusted): -20310009
Buyback yield (%): 0
Retained earnings: -141074640
Receivables turnover: 1.1267520373893234
Capitalized R&D asset: 30042217
ROCI (R&D-adjusted, %): -26.88467569232536
FCF margin (%): -1058.3426913158096
Rule of 40 score: -1058.3426913158096
Financial ratios for DARE — annual report dated 2023-12-31
Total revenue: 2807885
Operating income: -30939880
Net income: -30161391
Capital expenditures: 629430
Operating cash flow: -38856654
Depreciation & amortization: 38363
Net tangible assets: -5047640
Owner earnings: -30752458
Buffett classification: The Gruesome
Stock price: 3.71
Shares outstanding: 14979502
Book value: -5047640
Market cap (USD): 55573952.42
Debt to equity: -0.2782427035208533
Current ratio: 0.856599879026013
Quick ratio: 0.856599879026013
COGS to revenue (%): 0
R&D to revenue (%): 767.0568417153836
SG&A to revenue (%): 431.2744645881152
Free cash flow (dilution-adjusted): -42016768
Buyback yield (%): 0
Retained earnings: -171236031
Receivables turnover: 2.9581252218948157
Capitalized R&D asset: 41666359.39
ROCI (R&D-adjusted, %): -62.623974917619016
FCF margin (%): -1496.38493029451
Revenue growth (%): 46.31724524618833
Rule of 40 score: -1450.0676850483217
Financial ratios for DARE — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 9742
Buffett classification: The Gruesome
Stock price: 3.24
Shares outstanding: 14979502
Market cap (USD): 48533586.480000004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DARE — annual report dated 2024-12-31
Total revenue: 9784
Operating income: -23451485
Net income: -4053599
Capital expenditures: 573046
Operating cash flow: 5473555
Depreciation & amortization: 42325
Net tangible assets: -6012089
Owner earnings: -4584320
Buffett classification: The Gruesome
Stock price: 3.12
Shares outstanding: 14979502
Book value: -6012089
Market cap (USD): 46736046.24
Debt to equity: -0.21673348481700785
Current ratio: 0.8535513724174362
Quick ratio: 0.8535513724174362
COGS to revenue (%): 0
R&D to revenue (%): 146210.22076860178
SG&A to revenue (%): 93581.98078495503
Free cash flow (dilution-adjusted): 2697253
Buyback yield (%): 0
Retained earnings: -175289630
Receivables turnover: 0.042542459844683495
Capitalized R&D asset: 38649649.19
ROCI (R&D-adjusted, %): -79.48371906396507
FCF margin (%): 27567.99877350777
Revenue growth (%): -99.65155268111052
Rule of 40 score: 27468.34722082666
Financial ratios for DARE — quarterly report dated 2024-12-31
Capital expenditures: 562849
Depreciation & amortization: 6368
Buffett classification: The Gruesome
Stock price: 3.12
Shares outstanding: 14979502
Market cap (USD): 46736046.24
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DARE — quarterly report dated 2025-03-31
Total revenue: 25427
Gross profit: 25427
Operating income: -4581118
Net income: -4378307
Capital expenditures: 157331
Operating cash flow: -5470543
Depreciation & amortization: 175642
Net tangible assets: -9563701
Owner earnings: -4359996
Buffett classification: The Gruesome
Stock price: 2.89
Shares outstanding: 14979502
Book value: -9563701
Market cap (USD): 43290760.78
Debt to equity: -0.37356113496229126
Current ratio: 0.5579812964595083
Quick ratio: 0.5579812964595083
COGS to revenue (%): 0
R&D to revenue (%): 9035.202737247808
SG&A to revenue (%): 9081.54324143627
Free cash flow (dilution-adjusted): -6005231
Buyback yield (%): 0
Retained earnings: -179667937
Receivables turnover: 0.24162342969002415
Capitalized R&D asset: 2297381
FCF margin (%): -23617.536476973295
Rule of 40 score: -23617.536476973295
Financial ratios for DARE — quarterly report dated 2025-06-30
Total revenue: -21172
Gross profit: -21172
Operating income: -3827800
Net income: -4016483
Capital expenditures: 153396
Operating cash flow: -5417456
Depreciation & amortization: 442543
Net tangible assets: -12733260
Owner earnings: -3727336
Buffett classification: The Gruesome
Stock price: 2.39
Shares outstanding: 14979502
Book value: -12733260
Market cap (USD): 35801009.78
Debt to equity: -0.2381725496848411
Current ratio: 0.34349762654593435
Quick ratio: 0.34349762654593435
Free cash flow (dilution-adjusted): -5623078
Buyback yield (%): 0
Retained earnings: -183684420
Receivables turnover: -0.11254757702694082
Capitalized R&D asset: 2968007.27
Rosenberg metric: -0.02028353155179746
Revenue growth (%): -183.26581979785269
Rule of 40 score: -183.26581979785269
Financial ratios for DARE — quarterly report dated 2025-09-30
Total revenue: 2262
Gross profit: 2262
Operating income: -3672148
Net income: -3562766
Capital expenditures: 174702
Operating cash flow: -442135
Depreciation & amortization: 481906
Net tangible assets: 2857903
Owner earnings: -3255562
Return on net tangible assets (%): -113.91436308370157
Buffett classification: The Gruesome
Stock price: 2.1
Shares outstanding: 14979502
Book value: 2857903
P/B ratio: 11.00700555617178
Market cap (USD): 31456954.200000003
Debt to equity: 1.0261181012791547
Current ratio: 1.178531092512705
Quick ratio: 1.178531092512705
COGS to revenue (%): 0
R&D to revenue (%): 51952.60831122901
SG&A to revenue (%): 110488.15207780724
Free cash flow (dilution-adjusted): -1019864
Buyback yield (%): 0
Retained earnings: -187247186
Receivables turnover: 0.0061274742182865286
Capitalized R&D asset: 2890574.27
ROCI (R&D-adjusted, %): -33.25148548827677
Rosenberg metric: 0.01640161202495587
FCF margin (%): -45086.8258178603
Rule of 40 score: -45086.8258178603
Financial ratios for DARE — annual report dated 2025-12-31
Total revenue: 1030193
Gross profit: 734394
Operating income: -13552334
Net income: -13399274
Capital expenditures: 385278
Operating cash flow: -9885870
Depreciation & amortization: 1634486
Net tangible assets: 2842634
Owner earnings: -12150066
Return on net tangible assets (%): -427.4228057498784
Buffett classification: The Gruesome
Stock price: 1.93
Shares outstanding: 14979502
Book value: 2842634
P/B ratio: 10.170299398374887
Market cap (USD): 28910438.86
Debt to equity: 0.9343513797414651
Current ratio: 1.1426258820358473
Quick ratio: 1.1426258820358473
COGS to revenue (%): 28.71296931739975
R&D to revenue (%): 536.1473044371297
SG&A to revenue (%): 850.653809528894
Free cash flow (dilution-adjusted): -11767710
Buyback yield (%): 0
Retained earnings: -188688904
Receivables turnover: 1.797702164342016
Capitalized R&D asset: 22215405.78
ROCI (R&D-adjusted, %): -70.37047384233908
FCF margin (%): -1142.2820772418372
Revenue growth (%): 10429.364268192969
Rule of 40 score: 9287.082190951132
Financial ratios for DARE — quarterly report dated 2025-12-31
Total revenue: 1023676
Gross profit: 727877
Operating income: -1471268
Net income: -1441718
Capital expenditures: 206641
Operating cash flow: 1444264
Depreciation & amortization: 534395
Net tangible assets: 2842634
Owner earnings: -1113964
Return on net tangible assets (%): -39.187739258729756
Buffett classification: The Gruesome
Stock price: 1.93
Shares outstanding: 14979502
Book value: 2842634
P/B ratio: 10.170299398374887
Market cap (USD): 28910438.86
Debt to equity: 0.9343513797414651
Current ratio: 1.1426258820358473
Quick ratio: 1.1426258820358473
COGS to revenue (%): 28.895763894044602
R&D to revenue (%): 60.76541796427776
SG&A to revenue (%): 154.0628089356398
Free cash flow (dilution-adjusted): 880463
Buyback yield (%): 0
Retained earnings: -188688904
Receivables turnover: 1.786329902052312
Capitalized R&D asset: 1880895.02
ROCI (R&D-adjusted, %): -18.037413015323235
Rosenberg metric: 0.6174563977235595
FCF margin (%): 86.00992892282324
Revenue growth (%): 45155.349248452694
Rule of 40 score: 45241.35917737552
Financial ratios for EBRO.MC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.056818181818183
Shares outstanding: 153865392
Market cap (USD): 2470588623.818182
Buyback yield (%): 0
Capitalized R&D asset: 1629545.4545454546
Rule of 40 score: 0
Financial ratios for EBRO.MC — annual report dated 2022-12-31
Total revenue: 3157097872.3404255
Gross profit: 1360505319.1489363
Operating income: 248802127.65957448
Net income: 143242553.19148937
Capital expenditures: 121379787.23404256
Depreciation & amortization: 107471276.59574468
Net tangible assets: 987112765.9574468
Owner earnings: 129334042.55319151
Return on net tangible assets (%): 13.102256096115259
Capex to operating income (%): 48.78567091681846
Buffett classification: The Good
Stock price: 13.531914893617023
P/E ratio: 14.535438968569903
Shares outstanding: 153865392
Book value: 2338595744.680851
P/B ratio: 0.8903177876521645
Market cap (USD): 2082093389.6170216
Debt to equity: 0.33427042960860315
Current ratio: 1.9188821318127998
Quick ratio: 0.9455608309287595
Effective tax rate (%): 27.039885472560236
Interest coverage ratio: 29.02382725241996
COGS to revenue (%): 56.90645731738548
R&D to revenue (%): 0.053172992163554464
SG&A to revenue (%): 2.6000514881698518
Free cash flow (dilution-adjusted): -141303191.4893617
Buyback yield (%): 0.033977669399390655
Retained earnings: 2034931914.8936172
Inventory turnover: 1.994650764235593
Receivables turnover: 6.323196209072062
Capitalized R&D asset: 2770518.8588007735
ROCI (R&D-adjusted, %): 7.728956522613076
FCF margin (%): -4.475730471561548
Rule of 40 score: -4.475730471561548
Financial ratios for EBRO.MC — annual report dated 2023-12-31
Total revenue: 3427174444.444444
Gross profit: 1477503333.3333333
Operating income: 319383333.3333333
Net income: 227790000
Capital expenditures: 140020000
Depreciation & amortization: 114304444.44444445
Net tangible assets: 1068541111.111111
Owner earnings: 202074444.44444442
Return on net tangible assets (%): 18.91124659062668
Capex to operating income (%): 43.840734749256384
Buffett classification: The Good
Stock price: 15.499999999999998
P/E ratio: 10.469790491241932
Shares outstanding: 153865392
Book value: 2469036666.666666
P/B ratio: 0.96592878032053
Market cap (USD): 2384913575.9999995
Debt to equity: 0.28537175767607076
Current ratio: 1.3647126318199774
Quick ratio: 0.7631018971676266
Effective tax rate (%): 25.139397568804156
Interest coverage ratio: 18.516168513269776
COGS to revenue (%): 56.88858687282722
R&D to revenue (%): 0.05748175448709449
SG&A to revenue (%): 2.798353162323223
Free cash flow (dilution-adjusted): 374240000
Buyback yield (%): 0.03032954068492977
Retained earnings: 2183400000
Inventory turnover: 2.446361277676081
Receivables turnover: 7.123572436505902
Capitalized R&D asset: 3632494.6808510637
ROCI (R&D-adjusted, %): 10.722296124664954
Rosenberg metric: 69.69463455851277
FCF margin (%): 10.919782639213322
Revenue growth (%): 8.554583450522077
Rule of 40 score: 19.474366089735398
Financial ratios for EBRO.MC — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1113715625
Buffett classification: The Gruesome
Stock price: 15.510416666666668
Shares outstanding: 153865392
Book value: 2463696875
P/B ratio: 0.9686728772183063
Market cap (USD): 2386516340.5
Debt to equity: 0.21580796812378417
Current ratio: 1.4570261497884212
Quick ratio: 0.7425248240338246
Buyback yield (%): 0
Retained earnings: 2105144791.6666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EBRO.MC — annual report dated 2024-12-31
Total revenue: 3271346875
Gross profit: 1488859375
Operating income: 316048958.3333334
Net income: 238363541.6666667
Capital expenditures: 123080208.33333334
Depreciation & amortization: 112868750
Net tangible assets: 1113715625
Owner earnings: 228152083.33333334
Return on net tangible assets (%): 20.48566781428907
Capex to operating income (%): 38.94339946013111
Buffett classification: The Good
Stock price: 15.510416666666668
P/E ratio: 10.012086260395318
Shares outstanding: 153865392
Book value: 2463696875
P/B ratio: 0.9686728772183063
Market cap (USD): 2386516340.5
Debt to equity: 0.21580796812378417
Current ratio: 1.4570261497884212
Quick ratio: 0.7425248240338246
Effective tax rate (%): 25.91725669590104
Interest coverage ratio: 19.803341818419167
COGS to revenue (%): 54.48787817708875
R&D to revenue (%): 0.05167978403390805
SG&A to revenue (%): 3.090215453433585
Free cash flow (dilution-adjusted): 145669791.6666667
Buyback yield (%): 0.030771840424362686
Retained earnings: 2105144791.6666667
Inventory turnover: 2.0930145516413865
Receivables turnover: 7.047437065494971
Capitalized R&D asset: 3564503.723404255
ROCI (R&D-adjusted, %): 10.568270688463784
Rosenberg metric: 5.764488155668399
FCF margin (%): 4.452899592516207
Revenue growth (%): -4.546823395495537
Rule of 40 score: -0.09392380297932945
Financial ratios for EBRO.MC — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1134878823.5294118
Buffett classification: The Gruesome
Stock price: 19.6
Shares outstanding: 153865392
Book value: 2593721176.4705887
P/B ratio: 1.1627162204472972
Market cap (USD): 3015761683.2000003
Debt to equity: 0.2541803441160848
Current ratio: 1.36716147202998
Quick ratio: 0.6504483088292292
Buyback yield (%): 0
Retained earnings: 2358620000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EGLX.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.9291338582677167
Shares outstanding: 159169003
Market cap (USD): 466227315.87401575
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EGLX.TO — annual report dated 2022-12-31
Total revenue: 149144059.55882353
Gross profit: 46665088.97058823
Operating income: -34752245.58823529
Net income: -56493238.97058823
Capital expenditures: 8292.647058823528
Operating cash flow: -19588496.32352941
Depreciation & amortization: 12285179.411764706
Net tangible assets: -24950310.294117644
Owner earnings: -44216352.20588235
Buffett classification: The Gruesome
Stock price: 0.5441176470588235
Shares outstanding: 159169003
Book value: 187243387.5
P/B ratio: 0.46253523050077705
Market cap (USD): 86606663.39705881
Debt to equity: 0.07829628178144216
Current ratio: 0.8103601167554378
Quick ratio: 0.8103601167554378
Interest coverage ratio: -13.055421461770194
COGS to revenue (%): 68.71139949614744
R&D to revenue (%): 10.776398919992085
SG&A to revenue (%): 33.686219710561026
Free cash flow (dilution-adjusted): -25296325.735294115
Buyback yield (%): 0
Retained earnings: -167031587.5
Receivables turnover: 5.29789508128452
Capitalized R&D asset: 16072358.823529411
ROCI (R&D-adjusted, %): -10.744500053543732
FCF margin (%): -16.961001202543407
Rule of 40 score: -16.961001202543407
Financial ratios for EGLX.TO — annual report dated 2023-12-31
Total revenue: 134983429.54545453
Gross profit: 51077065.15151515
Operating income: -26578943.939393938
Net income: -89146672.72727272
Capital expenditures: 15477.272727272726
Operating cash flow: -2154137.121212121
Depreciation & amortization: 7903319.696969696
Net tangible assets: -36797450
Owner earnings: -81258830.30303028
Buffett classification: The Gruesome
Stock price: 0.21212121212121213
Shares outstanding: 159169003
Book value: 108118692.42424242
P/B ratio: 0.3122783035148367
Market cap (USD): 33763121.84848485
Debt to equity: 0.16618895560864877
Current ratio: 0.5278062652241484
Quick ratio: 0.5278062652241484
Interest coverage ratio: -14.325118337505547
COGS to revenue (%): 62.160492348199405
R&D to revenue (%): 13.976361419491182
SG&A to revenue (%): 36.280092898271405
Free cash flow (dilution-adjusted): -6337746.969696969
Buyback yield (%): 0
Retained earnings: -261239823.48484847
Receivables turnover: 5.6503527321619975
Capitalized R&D asset: 29634252.381461672
ROCI (R&D-adjusted, %): -12.836554858332406
Rosenberg metric: 0.27450707325348717
FCF margin (%): -4.695203693548759
Revenue growth (%): -9.494598749193853
Rule of 40 score: -14.189802442742613
Financial ratios for EGLX.TO — quarterly report dated 2024-09-30
Capital expenditures: 49217.777777777774
Buffett classification: The Gruesome
Stock price: 0.1037037037037037
Shares outstanding: 159169003
Market cap (USD): 16506415.125925925
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EGLX.TO — annual report dated 2024-12-31
Total revenue: 29135993.006993007
Gross profit: 21729169.230769232
Operating income: -867301.3986013987
Net income: -67120979.02097902
Capital expenditures: 1879745.4545454546
Operating cash flow: -13811218.181818182
Depreciation & amortization: 1562455.9440559442
Net tangible assets: -39454099.3006993
Owner earnings: -67438268.53146853
Buffett classification: The Gruesome
Stock price: 0.09090909090909091
Shares outstanding: 159169003
Book value: 36188368.53146853
P/B ratio: 0.39984972936963653
Market cap (USD): 14469909.363636363
Debt to equity: 0.7732236415568137
Current ratio: 0.3041512485476401
Quick ratio: 0.3041512485476401
Interest coverage ratio: -0.5714479889860982
COGS to revenue (%): 25.421559424612866
R&D to revenue (%): 22.3690016937693
SG&A to revenue (%): 49.823542697171
Free cash flow (dilution-adjusted): -13012341.25874126
Buyback yield (%): 0
Retained earnings: -308265431.4685315
Receivables turnover: 3.369845785030787
Capitalized R&D asset: 24461376.400692448
ROCI (R&D-adjusted, %): -11.623146532629063
Rosenberg metric: -1.555615957188807
FCF margin (%): -44.660709712616054
Revenue growth (%): -78.41513354260886
Rule of 40 score: -123.07584325522491
Financial ratios for EGLX.TO — quarterly report dated 2024-12-31
Capital expenditures: 3087.4125874125875
Buffett classification: The Gruesome
Stock price: 0.09090909090909091
Shares outstanding: 159169003
Market cap (USD): 14469909.363636363
Buyback yield (%): 0
Capitalized R&D asset: 4716118.181818182
Rule of 40 score: 0
Financial ratios for EGLX.TO — quarterly report dated 2025-03-31
Total revenue: 6281272.027972029
Gross profit: 5140746.153846154
Operating income: -239747.55244755244
Net income: -4226408.391608392
Capital expenditures: 0
Operating cash flow: -950723.076923077
Depreciation & amortization: 364885.3146853147
Net tangible assets: -43461345.45454545
Owner earnings: -3861523.076923077
Buffett classification: The Gruesome
Stock price: 0.06293706293706294
Shares outstanding: 159169003
Book value: 31940906.293706298
P/B ratio: 0.3136300976348456
Market cap (USD): 10017629.55944056
Debt to equity: 0.8421084907320984
Current ratio: 0.17373246380967808
Quick ratio: 0.17373246380967808
Interest coverage ratio: -0.4079381832157531
COGS to revenue (%): 18.157562179234326
R&D to revenue (%): 22.20598273099331
SG&A to revenue (%): 57.644219095526395
Free cash flow (dilution-adjusted): -989328.6713286714
Buyback yield (%): 0
Retained earnings: -312491839.86013985
Receivables turnover: 1.1494509592345166
Capitalized R&D asset: 4554617.363636364
ROCI (R&D-adjusted, %): -1.9108178939142098
FCF margin (%): -15.750450974308242
Rule of 40 score: -15.750450974308242
Financial ratios for EGLX.TO — quarterly report dated 2025-06-30
Total revenue: 7303405.109489051
Gross profit: 5847220.437956204
Operating income: -1918021.1678832115
Net income: -28562548.905109487
Capital expenditures: 613.1386861313869
Operating cash flow: -283418.24817518244
Depreciation & amortization: 561529.9270072993
Net tangible assets: -40378074.45255474
Owner earnings: -28001632.11678832
Buffett classification: The Gruesome
Stock price: 0.0364963503649635
Shares outstanding: 159169003
Book value: 4289924.817518249
P/B ratio: 1.3541234282260741
Market cap (USD): 5809087.700729926
Debt to equity: 6.483665427583929
Current ratio: 0.10867181156425904
Quick ratio: 0.10867181156425904
Interest coverage ratio: -1.4030422067745913
COGS to revenue (%): 19.93843487664238
R&D to revenue (%): 20.79227117837745
SG&A to revenue (%): 74.93364009288739
Free cash flow (dilution-adjusted): -314537.9562043795
Buyback yield (%): 0
Retained earnings: -354740162.7737226
Receivables turnover: 1.874974233700895
Capitalized R&D asset: 4009390.97743862
ROCI (R&D-adjusted, %): -29.585551780042106
Rosenberg metric: 0.5064991934569867
FCF margin (%): -4.306730237320557
Revenue growth (%): 16.27270840946253
Rule of 40 score: 11.965978172141973
Financial ratios for EGLX.TO — quarterly report dated 2025-09-30
Total revenue: 5259530.9352517985
Gross profit: 4568213.669064748
Operating income: -148708.6330935252
Net income: 5040069.7841726625
Capital expenditures: 0
Operating cash flow: -975056.1151079137
Depreciation & amortization: 181842.4460431655
Net tangible assets: -38381163.30935252
Owner earnings: 5221912.230215828
Return on net tangible assets (%): -13.60540374487133
Buffett classification: The Gruesome
Stock price: 0.05035971223021583
P/E ratio: 0.3975989187799586
Shares outstanding: 159169003
Book value: 5722330.935251795
P/B ratio: 1.400776235724237
Market cap (USD): 8015705.18705036
Debt to equity: 5.340491624382079
Current ratio: 0.1647940712728398
Quick ratio: 0.1647940712728398
Interest coverage ratio: -2.493907147338449
COGS to revenue (%): 16.534108411341766
R&D to revenue (%): 28.572575610594157
SG&A to revenue (%): 57.653361872136756
Free cash flow (dilution-adjusted): -1000803.5971223023
Buyback yield (%): 0
Retained earnings: -344595917.98561156
Receivables turnover: 0.994010712462803
Capitalized R&D asset: 2980497.7963031037
ROCI (R&D-adjusted, %): -1.1632810831072224
Rosenberg metric: -0.8422587300940414
FCF margin (%): -19.028381227201375
Revenue growth (%): -27.985222558470984
Rule of 40 score: -47.01360378567236
Financial ratios for EGLX.TO — quarterly report dated 2025-12-31
Total revenue: 5878679.562043795
Gross profit: 5849200.729927007
Operating income: 1416727.7372262774
Net income: -4343081.751824818
Capital expenditures: 0
Operating cash flow: 1722474.4525547444
Depreciation & amortization: 184792.700729927
Net tangible assets: -39601014.59854014
Owner earnings: -4158289.0510948906
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.029197080291970802
Shares outstanding: 159169003
Book value: 1300455.4744525552
P/B ratio: 3.5735711463249245
Market cap (USD): 4647270.160583941
Debt to equity: 25.651805319191915
Current ratio: 0.14529505217522934
Quick ratio: 0.14529505217522934
Interest coverage ratio: 2.047914382755845
COGS to revenue (%): 0.5014532907546272
R&D to revenue (%): 23.47956384763399
SG&A to revenue (%): 48.77612294632428
Free cash flow (dilution-adjusted): 1689572.9927007298
Buyback yield (%): 0
Retained earnings: -353969597.0802919
Receivables turnover: 1.6496314348356145
Capitalized R&D asset: 2888272.687391693
ROCI (R&D-adjusted, %): 23.785153911670474
Rosenberg metric: 0.8524096123780571
FCF margin (%): 28.740688701755484
Revenue growth (%): 11.771936212831788
Rule of 40 score: 40.51262491458727
Financial ratios for EGLX.TO — annual report dated 2025-12-31
Total revenue: 23382659.854014598
Gross profit: 20438608.02919708
Operating income: 456242.3357664233
Net income: -32203489.781021897
Capital expenditures: 613.1386861313869
Operating cash flow: -542594.8905109488
Depreciation & amortization: 1130783.211678832
Net tangible assets: -39601014.59854014
Owner earnings: -31073319.708029196
Capex to operating income (%): 0.13438881885027165
Buffett classification: The Great
Stock price: 0.029197080291970802
Shares outstanding: 159169003
Book value: 1300455.4744525552
P/B ratio: 3.5735711463249245
Market cap (USD): 4647270.160583941
Debt to equity: 25.651805319191915
Current ratio: 0.14529505217522934
Quick ratio: 0.14529505217522934
Interest coverage ratio: 0.17011411666408116
COGS to revenue (%): 12.590748200581853
R&D to revenue (%): 24.651376196048204
SG&A to revenue (%): 55.970685620050844
Free cash flow (dilution-adjusted): -673035.7664233577
Buyback yield (%): 0
Retained earnings: -353969597.0802919
Receivables turnover: 6.561468492737665
Capitalized R&D asset: 16356530.81064009
ROCI (R&D-adjusted, %): -21.837554962290856
Rosenberg metric: -0.19801686389443215
FCF margin (%): -2.8783541762371545
Revenue growth (%): -19.746480415469403
Rule of 40 score: -22.62483459170656
Financial ratios for EL — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 295.03
Shares outstanding: 247287571
Market cap (USD): 72957252072.12999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EL — annual report dated 2022-06-30
Total revenue: 17737000000
Gross profit: 13432000000
Operating income: 3544000000
Net income: 2408000000
Capital expenditures: 1040000000
Operating cash flow: 3040000000
Depreciation & amortization: 727000000
Net tangible assets: -359000000
Owner earnings: 2095000000
Return on net tangible assets (%): -583.5654596100278
Capex to operating income (%): 29.345372460496616
Buffett classification: The Good
Stock price: 238.09
P/E ratio: 24.450455888450996
Shares outstanding: 247287571
Book value: 6432000000
P/B ratio: 9.153715450775808
Market cap (USD): 58876697779.39
Debt to equity: 1.1885883084577114
Current ratio: 1.5989681857265692
Quick ratio: 1.0968185726569217
Effective tax rate (%): 20.685111989459813
Interest coverage ratio: 21.221556886227546
COGS to revenue (%): 24.271297288154706
SG&A to revenue (%): 55.74787168066753
Free cash flow (dilution-adjusted): 1669000000
Buyback yield (%): 3.921755273456036
Retained earnings: 13912000000
Inventory turnover: 1.4743150684931507
Receivables turnover: 10.888275015346839
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.477972838688306
FCF margin (%): 9.409708518915263
Rule of 40 score: 9.409708518915263
Financial ratios for EL — annual report dated 2023-06-30
Total revenue: 15910000000
Gross profit: 11346000000
Operating income: 1771000000
Net income: 1010000000
Capital expenditures: 0
Operating cash flow: 1731000000
Depreciation & amortization: 744000000
Net tangible assets: -2503000000
Owner earnings: 1754000000
Return on net tangible assets (%): -70.07590890930882
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 185.71
P/E ratio: 45.46908397070297
Shares outstanding: 247287571
Book value: 6417000000
P/B ratio: 7.156580148108151
Market cap (USD): 45923774810.41
Debt to equity: 1.5846968988623968
Current ratio: 1.4645833333333333
Quick ratio: 0.9871794871794872
Effective tax rate (%): 27.70221904080172
Interest coverage ratio: 6.9450980392156865
COGS to revenue (%): 28.686360779384035
SG&A to revenue (%): 60.182275298554366
Free cash flow (dilution-adjusted): -1825000000
Buyback yield (%): 0.5901082851285336
Retained earnings: 13991000000
Inventory turnover: 1.532057737495804
Receivables turnover: 10.957300275482094
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.311499272197961
FCF margin (%): -11.470773098680077
Revenue growth (%): -10.300501775948582
Rule of 40 score: -21.77127487462866
Financial ratios for EL — annual report dated 2024-06-30
Total revenue: 15608000000
Gross profit: 11184000000
Operating income: 1563000000
Net income: 409000000
Capital expenditures: 0
Operating cash flow: 2360000000
Depreciation & amortization: 825000000
Net tangible assets: -2012000000
Owner earnings: 1234000000
Return on net tangible assets (%): -61.33200795228628
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 102.58
P/E ratio: 62.02141572904645
Shares outstanding: 247287571
Book value: 5314000000
P/B ratio: 4.77357151546481
Market cap (USD): 25366759033.18
Debt to equity: 1.849077907414377
Current ratio: 1.389337074710628
Quick ratio: 1.0078919677306208
Effective tax rate (%): 47.020725388601036
Interest coverage ratio: 4.134920634920635
COGS to revenue (%): 28.344438749359302
SG&A to revenue (%): 61.64146591491543
Free cash flow (dilution-adjusted): 1116000000
Buyback yield (%): 0.1379758445066617
Retained earnings: 13427000000
Inventory turnover: 2.0340229885057473
Receivables turnover: 9.037637521713954
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.784037558685446
FCF margin (%): 7.150179395181958
Revenue growth (%): -1.8981772470144562
Rule of 40 score: 5.252002148167501
Financial ratios for EL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 96.82
Shares outstanding: 247287571
Market cap (USD): 23942382624.219997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 73.17
Shares outstanding: 247287571
Market cap (USD): 18094031570.07
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EL — quarterly report dated 2025-03-31
Total revenue: 3550000000
Gross profit: 2661000000
Operating income: 403000000
Net income: 159000000
Capital expenditures: 122000000
Operating cash flow: 284000000
Depreciation & amortization: 204000000
Net tangible assets: -1864000000
Owner earnings: 241000000
Return on net tangible assets (%): -12.929184549356224
Capex to operating income (%): 30.272952853598017
Buffett classification: The Good
Stock price: 64.71
P/E ratio: 25.160343898443394
Shares outstanding: 247287571
Book value: 4345000000
P/B ratio: 3.682848957286536
Market cap (USD): 16001978719.409998
Debt to equity: 2.1592635212888376
Current ratio: 1.4135777598710717
Quick ratio: 1.0189363416599517
Effective tax rate (%): 34.024896265560166
Interest coverage ratio: 4.632183908045977
COGS to revenue (%): 25.04225352112676
SG&A to revenue (%): 63.6056338028169
Free cash flow (dilution-adjusted): 87000000
Buyback yield (%): 0
Retained earnings: 12344000000
Inventory turnover: 0.45380296069423176
Receivables turnover: 1.9810267857142858
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7007103605414824
FCF margin (%): 2.450704225352113
Rule of 40 score: 2.450704225352113
Financial ratios for EL — quarterly report dated 2025-06-30
Total revenue: 3411000000
Gross profit: 2456000000
Operating income: 141000000
Net income: -546000000
Capital expenditures: 0
Operating cash flow: 601000000
Depreciation & amortization: 210000000
Net tangible assets: -2029000000
Owner earnings: -336000000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 79.63
Shares outstanding: 247287571
Book value: 3865000000
P/B ratio: 5.09482775646313
Market cap (USD): 19691509278.73
Debt to equity: 2.449417852522639
Current ratio: 1.3006439742410303
Quick ratio: 0.9190432382704692
Interest coverage ratio: 1.6022727272727273
COGS to revenue (%): 27.997654646731164
SG&A to revenue (%): 67.86866021694517
Free cash flow (dilution-adjusted): 345000000
Buyback yield (%): 0
Retained earnings: 11672000000
Inventory turnover: 0.4604628736740598
Receivables turnover: 2.2294117647058824
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9753060800996057
FCF margin (%): 10.11433597185576
Revenue growth (%): -3.915492957746479
Rule of 40 score: 6.198843014109282
Financial ratios for EL — annual report dated 2025-06-30
Total revenue: 14326000000
Gross profit: 10597000000
Operating income: 1141000000
Net income: -1133000000
Capital expenditures: 3000000
Operating cash flow: 1272000000
Depreciation & amortization: 829000000
Net tangible assets: -2029000000
Owner earnings: -307000000
Capex to operating income (%): 0.26292725679228746
Buffett classification: The Great
Stock price: 79.63
Shares outstanding: 247287571
Book value: 3865000000
P/B ratio: 5.09482775646313
Market cap (USD): 19691509278.73
Debt to equity: 2.449417852522639
Current ratio: 1.3006439742410303
Quick ratio: 0.9190432382704692
Interest coverage ratio: 3.196078431372549
COGS to revenue (%): 26.029596537763506
SG&A to revenue (%): 66.00586346502863
Free cash flow (dilution-adjusted): 366000000
Buyback yield (%): 0.17774158143279364
Retained earnings: 11672000000
Inventory turnover: 1.7979749276759884
Receivables turnover: 9.363398692810458
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.89237047796915
FCF margin (%): 2.554795476755549
Revenue growth (%): -8.213736545361353
Rule of 40 score: -5.658941068605804
Financial ratios for EL — quarterly report dated 2025-09-30
Total revenue: 3481000000
Gross profit: 2554000000
Operating income: 258000000
Net income: 47000000
Capital expenditures: 96000000
Operating cash flow: -340000000
Depreciation & amortization: 200000000
Net tangible assets: -1935000000
Owner earnings: 151000000
Return on net tangible assets (%): -7.803617571059432
Capex to operating income (%): 37.2093023255814
Buffett classification: The Good
Stock price: 87.18
P/E ratio: 114.67303425414893
Shares outstanding: 247287571
Book value: 3890000000
P/B ratio: 5.542038673465297
Market cap (USD): 21558530439.780003
Debt to equity: 2.422107969151671
Current ratio: 1.320873499901633
Quick ratio: 0.9152075545937438
Effective tax rate (%): 56.88073394495413
Interest coverage ratio: 3
COGS to revenue (%): 26.630278655558747
SG&A to revenue (%): 65.95805802930192
Free cash flow (dilution-adjusted): -524000000
Buyback yield (%): 0.041746815837656145
Retained earnings: 11591000000
Inventory turnover: 0.4495635305528613
Receivables turnover: 1.8476645435244161
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8110346764003933
FCF margin (%): -15.053145647802355
Revenue growth (%): 2.052184110231604
Rule of 40 score: -13.00096153757075
Financial ratios for EL — quarterly report dated 2025-12-31
Total revenue: 4229000000
Gross profit: 3235000000
Operating income: 608000000
Net income: 162000000
Capital expenditures: 108000000
Operating cash flow: 1125000000
Depreciation & amortization: 197000000
Net tangible assets: -1802000000
Owner earnings: 251000000
Return on net tangible assets (%): -13.92896781354051
Capex to operating income (%): 17.763157894736842
Buffett classification: The Great
Stock price: 103.99
P/E ratio: 39.684312512793205
Shares outstanding: 247287571
Book value: 4031000000
P/B ratio: 6.379418136514513
Market cap (USD): 25715434508.289997
Debt to equity: 2.329446787397668
Current ratio: 1.3579965850882185
Quick ratio: 0.9984822614304686
Effective tax rate (%): 51.35135135135135
Interest coverage ratio: 7.152941176470589
COGS to revenue (%): 23.504374556632772
SG&A to revenue (%): 62.11870418538662
Free cash flow (dilution-adjusted): 923000000
Buyback yield (%): 0.22554547923855725
Retained earnings: 11624000000
Inventory turnover: 0.5245382585751979
Receivables turnover: 2.552202776101388
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.233098934762933
FCF margin (%): 21.82549065973043
Revenue growth (%): 21.48807813846596
Rule of 40 score: 43.313568798196386
Financial ratios for FMONC.PA — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 83.79545454545453
Shares outstanding: 18642900
Market cap (USD): 1562190279.5454543
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FMONC.PA — annual report dated 2022-12-31
Total revenue: 14893.617021276597
Gross profit: -404255.3191489362
Operating income: -404255.3191489362
Net income: 10104255.319148937
Capital expenditures: 0
Operating cash flow: 4655319.14893617
Depreciation & amortization: 0
Net tangible assets: 1795092553.1914895
Owner earnings: 10104255.319148937
Return on net tangible assets (%): 0.5628821367001168
Buffett classification: The Gruesome
Stock price: 68.82978723404256
P/E ratio: 126.99469677826909
Shares outstanding: 18642900
Book value: 1817397872.3404255
P/B ratio: 0.706057193064201
Market cap (USD): 1283186840.4255319
Debt to equity: 0
Current ratio: 25.176470588235293
Quick ratio: 25.176470588235293
Effective tax rate (%): 2.7165556125064065
COGS to revenue (%): 2814.285714285714
Free cash flow (dilution-adjusted): 4655319.14893617
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.02224363334531368
FCF margin (%): 31257.142857142855
Rule of 40 score: 31257.142857142855
Financial ratios for FMONC.PA — annual report dated 2023-12-31
Total revenue: 185555.55555555556
Gross profit: -456666.6666666666
Operating income: -456666.6666666666
Net income: 14978888.888888888
Capital expenditures: 0
Operating cash flow: 9086666.666666666
Depreciation & amortization: 0
Net tangible assets: 1996617777.7777777
Owner earnings: 14978888.888888888
Return on net tangible assets (%): 0.7502131382181867
Buffett classification: The Gruesome
Stock price: 84.27777777777777
P/E ratio: 104.89310622357392
Shares outstanding: 18642900
Book value: 2021956666.6666667
P/B ratio: 0.7770602650567849
Market cap (USD): 1571182183.3333333
Debt to equity: 0
Current ratio: 49.942148760330575
Quick ratio: 49.942148760330575
Effective tax rate (%): 2.134301270417423
COGS to revenue (%): 346.1077844311377
Free cash flow (dilution-adjusted): 9086666.666666666
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.022585383465191306
FCF margin (%): 4897.005988023951
Revenue growth (%): 1145.873015873016
Rule of 40 score: 6042.879003896967
Financial ratios for FMONC.PA — annual report dated 2024-12-31
Total revenue: 1752083.3333333335
Gross profit: 1140625
Operating income: 1140625
Net income: 9617708.333333334
Capital expenditures: 0
Operating cash flow: 8604166.666666668
Depreciation & amortization: 0
Net tangible assets: 2165605208.3333335
Owner earnings: 9617708.333333334
Return on net tangible assets (%): 0.4441118028495691
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 143.94791666666666
P/E ratio: 279.02765634138416
Shares outstanding: 18642900
Book value: 2165605208.3333335
P/B ratio: 1.239194755026621
Market cap (USD): 2683606615.625
Debt to equity: 4.81004876908447e-07
Current ratio: 23.174129353233834
Quick ratio: 23.174129353233834
Effective tax rate (%): 2.902513408349984
COGS to revenue (%): 34.89892984542212
Free cash flow (dilution-adjusted): 8604166.666666668
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.0526700086869439
FCF margin (%): 491.08204518430443
Revenue growth (%): 844.2365269461078
Rule of 40 score: 1335.3185721304121